Clinicopathological characteristics, outcomes and pattern of mutations in patients with follicular lymphoma who progressed on Bruton tyrosine kinase inhibitors
暂无分享,去创建一个
Michael L. Wang | Y. Oki | P. Jain | R. Kanagal-Shamanna | L. Medeiros | F. A. San Lucas | L. Fayad | J. Westin | J. Romaguera | L. Nastoupil | N. Fowler